US Stock MarketDetailed Quotes

MLTX MoonLake Immunotherapeutics

Watchlist

48.940
+0.860+1.79%

Close Oct 18 16:00 ET

48.940
0.0000.00%

Post 16:00 ET

3.08BMarket Cap-56252P/E (TTM)

MoonLake Immunotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-129.38%-27.89M

-65.64%-14.95M

23.47%-42.78M

-6.45%-12.34M

1.08%-9.25M

41.43%-12.16M

36.38%-9.02M

-55.89M

-11.6M

-363.27%-9.35M

Net income from continuing operations

-100.42%-24.76M

-14.38%-13.98M

31.67%-44.08M

52.10%-7.89M

21.18%-11.62M

29.07%-12.35M

23.05%-12.22M

---64.51M

---16.47M

-134.44%-14.74M

Operating gains losses

97.99%-272

97.95%-272

-128.04%-85.25K

-145.21%-34.51K

-131.40%-23.96K

-118.18%-13.51K

-117.22%-13.27K

--304.03K

--76.34K

-47.50%76.31K

Depreciation and amortization

754.73%28.11K

593.40%22.81K

6.47%13.16K

0.00%3.29K

-0.09%3.29K

0.03%3.29K

32.23%3.29K

--12.36K

--3.29K

45.00%3.29K

Other non cash items

5,310.86%333.47K

75.81%171.65K

119.47%484.76K

123.62%506.23K

-374.17%-125.26K

-61.57%6.16K

1,902.28%97.63K

--220.88K

--226.38K

---26.42K

Change In working capital

-309.62%-5.32M

-636.93%-2.84M

-293.55%-6.22M

-431.95%-6.54M

-60.42%1.09M

78.06%-1.3M

239.72%529.72K

---1.58M

--1.97M

21.99%2.75M

-Change in receivables

25.02%-180.94K

-172.15%-439.01K

-1,128.49%-839.73K

-187.66%-336.11K

-132.22%-100.99K

-1,083.98%-241.32K

62.73%-161.32K

---68.36K

--383.41K

22.39%-43.49K

-Change in prepaid assets

-824.40%-8.18M

-175.44%-832.51K

-132.43%-6.35M

-2,507.34%-7.22M

2.62%650.1K

68.59%-884.52K

230.15%1.1M

---2.73M

--299.73K

37,766.59%633.51K

-Change in payables and accrued expense

2,607.56%3.35M

-210.83%-1.16M

-8.41%1.26M

-9.51%1.3M

-78.64%461.67K

95.73%-133.76K

-141.45%-373.74K

--1.37M

--1.44M

-6.42%2.16M

-Change in other current assets

---1

---5.44K

---65.51K

----

--0

----

-Change in other current liabilities

-705.97%-317.91K

-944.62%-405.58K

-45.82%-222.26K

----

---39.45K

---38.83K

---152.43K

----

Cash from discontinued investing activities

Operating cash flow

-129.38%-27.89M

-65.64%-14.95M

23.47%-42.78M

-6.45%-12.34M

1.08%-9.25M

41.43%-12.16M

36.38%-9.02M

---55.89M

---11.6M

-363.27%-9.35M

Investing cash flow

Cash flow from continuing investing activities

-792.19%-87.74M

-246.60%-28.8M

22.13%-25.18M

1,080.30%116.87M

-312.96%-174.38M

633,802,550.00%12.68M

122,826.62%19.65M

-32.34M

9.9M

-362,386.24%-42.23M

Net PPE purchase and sale

--0

---211.77K

-1,677.96%-284.63K

-28,463,300.00%-284.63K

--0

---16.01K

---1

--0

Net investment purchase and sale

-792.19%-87.74M

-245.52%-28.59M

22.97%-24.9M

1,083.17%117.15M

-312.96%-174.38M

--12.68M

--19.65M

---32.32M

--9.9M

---42.23M

Cash from discontinued investing activities

Investing cash flow

-792.19%-87.74M

-246.60%-28.8M

22.13%-25.18M

1,080.30%116.87M

-312.96%-174.38M

633,802,550.00%12.68M

122,826.62%19.65M

---32.34M

--9.9M

-362,386.24%-42.23M

Financing cash flow

Cash flow from continuing financing activities

50.98M

300.78%479.7M

749,475.71%28.42M

331.09%451.29M

119.69M

3.79K

Net issuance payments of debt

----

--0

----

---15M

--0

Net common stock issuance

--0

--52.54M

--482.45M

--31.17M

--0

--451.29M

--0

Proceeds from stock option exercised by employees

----

--0

----

--3.79K

----

Net other financing activities

--0

---1.56M

-102.04%-2.75M

----

--134.69M

--0

Cash from discontinued financing activities

Financing cash flow

--0

--50.98M

300.78%479.7M

749,475.71%28.42M

--0

331.09%451.29M

--0

--119.69M

--3.79K

--0

Net cash flow

Beginning cash position

814.52%458.44M

1,042.04%451.17M

391.43%39.51M

672.16%318.17M

441.26%501.79M

467.45%50.13M

391.43%39.51M

--8.04M

--41.2M

4,443.42%92.71M

Current changes in cash

-125.59%-115.63M

-31.99%7.23M

1,208.84%411.74M

7,962.69%132.94M

-256.02%-183.63M

438.34%451.8M

1,225.00%10.62M

--31.46M

---1.69M

-3,266.85%-51.58M

Effect of exchange rate changes

88.30%-16.9K

8,786.92%46.48K

-981.81%-75.31K

881.32%64.74K

-93.26%5.01K

-183.38%-144.52K

91.77%-535

--8.54K

---8.29K

7,495.82%74.33K

End cash Position

-31.69%342.79M

814.52%458.44M

1,042.04%451.17M

672.16%318.17M

441.26%501.79M

467.45%50.13M

--39.51M

8,018.17%41.2M

Free cash flow

-129.38%-27.89M

-67.99%-15.16M

22.98%-43.06M

-8.91%-12.63M

1.08%-9.25M

41.43%-12.16M

36.46%-9.02M

---55.91M

---11.6M

-360.61%-9.35M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-129.38%-27.89M	-65.64%-14.95M	23.47%-42.78M	-6.45%-12.34M	1.08%-9.25M	41.43%-12.16M	36.38%-9.02M	-55.89M	-11.6M	-363.27%-9.35M
Net income from continuing operations	-100.42%-24.76M	-14.38%-13.98M	31.67%-44.08M	52.10%-7.89M	21.18%-11.62M	29.07%-12.35M	23.05%-12.22M	---64.51M	---16.47M	-134.44%-14.74M
Operating gains losses	97.99%-272	97.95%-272	-128.04%-85.25K	-145.21%-34.51K	-131.40%-23.96K	-118.18%-13.51K	-117.22%-13.27K	--304.03K	--76.34K	-47.50%76.31K
Depreciation and amortization	754.73%28.11K	593.40%22.81K	6.47%13.16K	0.00%3.29K	-0.09%3.29K	0.03%3.29K	32.23%3.29K	--12.36K	--3.29K	45.00%3.29K
Other non cash items	5,310.86%333.47K	75.81%171.65K	119.47%484.76K	123.62%506.23K	-374.17%-125.26K	-61.57%6.16K	1,902.28%97.63K	--220.88K	--226.38K	---26.42K
Change In working capital	-309.62%-5.32M	-636.93%-2.84M	-293.55%-6.22M	-431.95%-6.54M	-60.42%1.09M	78.06%-1.3M	239.72%529.72K	---1.58M	--1.97M	21.99%2.75M
-Change in receivables	25.02%-180.94K	-172.15%-439.01K	-1,128.49%-839.73K	-187.66%-336.11K	-132.22%-100.99K	-1,083.98%-241.32K	62.73%-161.32K	---68.36K	--383.41K	22.39%-43.49K
-Change in prepaid assets	-824.40%-8.18M	-175.44%-832.51K	-132.43%-6.35M	-2,507.34%-7.22M	2.62%650.1K	68.59%-884.52K	230.15%1.1M	---2.73M	--299.73K	37,766.59%633.51K
-Change in payables and accrued expense	2,607.56%3.35M	-210.83%-1.16M	-8.41%1.26M	-9.51%1.3M	-78.64%461.67K	95.73%-133.76K	-141.45%-373.74K	--1.37M	--1.44M	-6.42%2.16M
-Change in other current assets	---1	---5.44K	---65.51K	----	----	--0	--0	--0	----	----
-Change in other current liabilities	-705.97%-317.91K	-944.62%-405.58K	-45.82%-222.26K	----	----	---39.45K	---38.83K	---152.43K	----	----
Cash from discontinued investing activities
Operating cash flow	-129.38%-27.89M	-65.64%-14.95M	23.47%-42.78M	-6.45%-12.34M	1.08%-9.25M	41.43%-12.16M	36.38%-9.02M	---55.89M	---11.6M	-363.27%-9.35M
Investing cash flow
Cash flow from continuing investing activities	-792.19%-87.74M	-246.60%-28.8M	22.13%-25.18M	1,080.30%116.87M	-312.96%-174.38M	633,802,550.00%12.68M	122,826.62%19.65M	-32.34M	9.9M	-362,386.24%-42.23M
Net PPE purchase and sale	--0	---211.77K	-1,677.96%-284.63K	-28,463,300.00%-284.63K	--0	--0	--0	---16.01K	---1	--0
Net investment purchase and sale	-792.19%-87.74M	-245.52%-28.59M	22.97%-24.9M	1,083.17%117.15M	-312.96%-174.38M	--12.68M	--19.65M	---32.32M	--9.9M	---42.23M
Cash from discontinued investing activities
Investing cash flow	-792.19%-87.74M	-246.60%-28.8M	22.13%-25.18M	1,080.30%116.87M	-312.96%-174.38M	633,802,550.00%12.68M	122,826.62%19.65M	---32.34M	--9.9M	-362,386.24%-42.23M
Financing cash flow
Cash flow from continuing financing activities	0	50.98M	300.78%479.7M	749,475.71%28.42M	0	331.09%451.29M	0	119.69M	3.79K	0
Net issuance payments of debt	----	----	--0	--0	----	----	----	---15M	--0	--0
Net common stock issuance	--0	--52.54M	--482.45M	--31.17M	--0	--451.29M	--0	--0	--0	--0
Proceeds from stock option exercised by employees	----	----	--0	----	----	----	----	--3.79K	----	----
Net other financing activities	--0	---1.56M	-102.04%-2.75M	----	----	----	----	--134.69M	--0	--0
Cash from discontinued financing activities
Financing cash flow	--0	--50.98M	300.78%479.7M	749,475.71%28.42M	--0	331.09%451.29M	--0	--119.69M	--3.79K	--0
Net cash flow
Beginning cash position	814.52%458.44M	1,042.04%451.17M	391.43%39.51M	672.16%318.17M	441.26%501.79M	467.45%50.13M	391.43%39.51M	--8.04M	--41.2M	4,443.42%92.71M
Current changes in cash	-125.59%-115.63M	-31.99%7.23M	1,208.84%411.74M	7,962.69%132.94M	-256.02%-183.63M	438.34%451.8M	1,225.00%10.62M	--31.46M	---1.69M	-3,266.85%-51.58M
Effect of exchange rate changes	88.30%-16.9K	8,786.92%46.48K	-981.81%-75.31K	881.32%64.74K	-93.26%5.01K	-183.38%-144.52K	91.77%-535	--8.54K	---8.29K	7,495.82%74.33K
End cash Position	-31.69%342.79M	814.52%458.44M	1,042.04%451.17M	1,042.04%451.17M	672.16%318.17M	441.26%501.79M	467.45%50.13M	--39.51M	--39.51M	8,018.17%41.2M
Free cash flow	-129.38%-27.89M	-67.99%-15.16M	22.98%-43.06M	-8.91%-12.63M	1.08%-9.25M	41.43%-12.16M	36.46%-9.02M	---55.91M	---11.6M	-360.61%-9.35M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data